Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-binding cassette sub-family A member 4 (ABCA4) is a retina-specific ABC transporter responsible for transporting N-retinylidene-phosphatidylethanolamine (N-retinylidene-PE), a toxic byproduct of the visual cycle, out of photoreceptor disc membranes. Mutations in ABCA4 are associated with several inherited retinal diseases, including Stargardt macular degeneration and cone-rod dystrophy, due to the accumulation of toxic retinoids.
Modulation of ABCA4 activity to enhance N-retinylidene-PE transport and reduce toxic retinoid accumulation is a potential therapeutic approach.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-binding cassette sub-family A member 4 (ABCA4).